Stocks retreat on Johnson & Johnson results, Goldman downgrade

A mixed earnings report from Johnson & Johnson (JNJ) and a key analyst downgrade left stocks mostly lower Tuesday.

J&J, a component of the Dow Jones Industrial Average ($INDU), said third-quarter sales fell five percent, more than Wall Street had feared. The results created concern among investors that much needed corporate revenue growth could be more anemic this reporting season than previously thought.
The blue-chip Dow slipped 15 points, or 0.2 percent, to close at 9,871, while the broader S&P 500 ($INX) declined three points, or 0.3 percent, to 1,073. The tech-heavy Nasdaq Composite ($COMPX) was essentially unchanged at 2,140.

Financial stocks sold off after well-known bank analyst Meredith Whitney cut her rating on Goldman Sachs (GS) to Neutral from Buy. Shares in Goldman finished the day off 1.5 percent, while rival Morgan Stanley (MS) dropped two percent.

For more on stocks making moves today, be sure to check out BloggingStocks' market wrap up.
Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.